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I SHOULiD LIKE to summarize for you some of our studies in man which suggest an interaction between the amide of synthetic valyl-5-angiotensin II, norepinephrine, aldosterone secretion, and sodium and potassium excretion by the kidney.
The studies which I shall report were carried out in normal volunteers and in patients with hypertension or with cirrhosis and ascites. All studies were conducted under conlitions of controlled metabolism balance.
Our interest in angiotensin developed as an outgrowth of a long-standing interest in aldosterone netabolism and in the factors concerned with the regulation of the rate of secretion of this hormonle. Therefore, I should tike first to review briefly some of our work on aldosterone secretion which resulted in our inivestigation of the relation of angiotensin to aldosteronie and to electrolyte balance.
Aldosterone Oversecretion in Man
Many studies of aldosterone have been based on quantitation of the small fraction of hormone excreted unchanlged in the urine. By contrast, our work has employed a technic of isotope dilution which measures with precision the amount of the hormone actually secreted by the adrenal cortex. Details of this method have been previously described. 1 We have found marked oversecretion of aldosterone in the edematous states of cirrhosis and nephrosis. Of interest was the finding that in advanced heart failure, aldosterone secretion may not be much elevated,2 pointing again to the fact that hemodynamie rather than hormonal factors may be more important in the sodium retention accompanying this condition.
An increased mean urinary exeretionl of aldosterone has been reported in patients with benign hypertension with the suggestion that this condition represents mild, chronic hyperaldosteronism. 3 Results from our laboratory do not support this opinion. In our hands, the secretory rate of aldosterone was normal in the frequenitly occurring forms of hypertension, and there was no indication that aldosterone was involved in the pathogenesis of primary (benign essential) hypertension. On the other hand, in the much less common syndrome of malignant hypertension, oversecretion of aldosterone was a most consistent finding. It is possible that aldosterone hypersecretion is in itself a cause of malignant hypertension, but for a number of reasons,4 we have felt that it is an associated phenomeiion or even a consequence of the disease process.
I am pleased that Davis and his group5 lhave graciously allowed me to report their as yet unpublished data in hypertensive dogs. These studies, in a well-controlled experimental model, seem to agree entirely with our concept of the relation of aldosterone to hypertension in man. These workers found no increase in aldosterone secretion after production of a sustained hypertension by the Goldblatt technic. However, when the clamps were tightened so that a malignant stage (with a hastened demise) was produced, aldosterone secretion then increased markedly.
Problem of the Control of Aldosterone Secretion
Abnormalities in aldosterone secretion, which occur in these various diseases, may provide additional clues, not only for understanding the disease in question, but also for Circulation, Volume XXV, January 1962 LARAGH studying the basic problem of the factors ilvolved in the physiologie control of aldosteroine release. In this latter regard, it is known, -8 for example, that aldosteronle secretion is largely independent of ACTII. Rather, it fluctuates widely aceording to the state of sodium an-d potassium balance or according to the volume or distributioni of fluid in the vascular bed. Bleeding alid thoracie eaval occlusion are potent stim-Lli for aldosterolie secretion in dogs. How these stimuli are mediated is poorly uinder stood. AVhat these various stimuli for aldosterone secretionl halve ini common also remains obscure. Our approach has been that there is probably 1 mrlaiii efferent pathway for the eontrol of aldosterone secretion which, if exposed, might accoulnt for most of the situations in which oversecretion occurs.
More recently,9 our investigations of this problem have followed 3 rather parallel avenues. First, we studied the effect on aldosterone seeretion resulting from altering the arterial pressure itself by various mean-s.
Secondly, we investigated the specific effects of norepinephrine anjd of epinephrille on aldosterone secretioli because of the possibility that the autonomic nervous system mighb mnediate eontrol to the adrenal cortex. Thirdly, because of our observationis in malignant hypertension, where there is always renial danage, and because of the enormous literature relating the adrenal cortex anid the kidneys to experimenital hypertenlsioni, we inivestigated the possible trophic effects of a pressor substance of renal origin, angiotensill, on aldosterone secretion. Because angiotensin and norepinephrine were given in equipressor dosage, it seemed possible that any lifference in their effect on aldosterone re- Substances to Aldosterone Secretion and to Sodium Balance At the outset, I would like to emphasize that certain controls seem essential to proper study of the possible specific influences of any pressor substance on aldosterone secretion and oin eleetrolyte balance. Three of these will be mentioned.
First, it is important to control the nonspeeific ilifluelnces of the induced hemodyimamic ehanges. Changes in vascular pressure anid flow prodluced by vasoactive drugs might well affect aldosterone anid sodiuin metabolism. Therefore, onie must try to establish that atn observed change is not just a consequence of the altered circulation but is rather a unique chemnotrophic effect of the particular agent. Different pressor agents must be conpared under sinilar eircumstances to see whether an observed effect on aldosterone or on sodium exeretion occurs with all of them. This vital contiol has not always been provrided. We have tried to eompare systeinatieally the effects of angiotensin with those of norepinephrimne and epinephrine, amonig others, but eveni this collation may not be erntirely adequate becauise differences do exist in the heimnodynamic actions of these a gents.
Secondly, it seems important to control the state of sodium:l balanee durinog administrationi of pressor agents because, as I will show you, the effect of these agents on salt excretion and on the rate of aldosteron-e secretion may at times be different after sodiumn depletion. This factor too has not always been controlled in reported studies.
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Thirdly, I would like to say a word about the differing sensitivity of various patients to dosages of pressor agents. Recently, the provocative studies of Wood'0 demonstrated that hypertensive subjects may be more sensitive to angiotensin. Some time ago, Goldenberg demonstrated that hypertensive subjects are also more sensitive to norepinephrine," so that less drug is necessary to produce a rise in blood pressure. It seems uncertain, therefore, whether this phenomenon of increased sensitivity is unique or whether it is just a nonspecific reflection of an increased vascular reactivity of hypertensive subjects. On the other hand, patients with cirrhosis and ascites appear to have a reduced sensitivity to pressor drugs. In table 1, data are shown which indicate that more angiotensin or more norepinephrine must be given to produce rises in blood pressure similar to those of normal controls. Again, the specificity of such phenomena remains to be established, and the altered sensitivity to various pressor agents in these diseases could be the result of the altered circulatory dynamics associated with the disease.
Relation of Norepinephrine, Epinephrine, and
Angiotensin to Aldosterone Secretion and to Electrolyte Balance
Let us now consider the effects of infusion of these pressor substan&es on aldosterone secretion under different conditions of sodium balance.
The medullary hormones have a variable effect on aldosterone secretion. In a previously reported study,9 it appeared that the effect of norepinephrine or of epinephrine on aldosterone secretion might be determined by the pre-existing state of sodium balance. Thus, in subjects in a normal state of sodium balance with an initially normal rate of aldosterone secretion, no consistent changes were produced by norepinephrine or epinephrine infusions. However, in sodium-depleted subjects with an initially high rate of secretion of aldosterone, these hormones often produced a profound reduction in aldosterone secretion with natriuresis. This suppressive effect of the medullary hormones on aldosterone secretion may, at times, be of clinical signifieanee; Circulation, Volume XXV, January 1962 it seems possible that activity of the autonomic nervous system plays some balancing role in regulation of aldosterone secretion. For example, we have studied a patient in whom oral administration of sympathomimetic drugs has led to sustained correction of excess aldosterone secretion and to complete diuresis of edema fluid. These agents were more effective than conventional diuretic agents in this patient. 12 We compared the effects of angiotensin with those of norepinephrine. Angliotensin was given in amounts sufficient to produce pressure changes sililar to those following norepinephrine administration. The effects of angiotensin on aldosteronae secretion differed sharply from those of norepinephrine. Ang,iotensin consistently produced an increase in aldosterone secretion to levels of from 35 to 250 per cent above the control values.6 Also, in contrast to epinephrine and norepinephrine, this action of angiotensin was independent of the state of sodium balance. It occurred in subj ects ingesting normal amounts of sodium as well as in sodium-depleted subjects.
In figure 1 , additional data are presented which point up the possible influence of sodium depletion on the action of these pressor substances. Normal subjects on constant, but unrestricted, intake of sodium are conmpared with normial subjects studied in a similar manner after sodium depletion. The open boxes represent the control study, during which a dextrose infusion without pressor agent was administered. Angiotensin infusion always produced an increased aldosterone secretion. In contrast, the hormones of the autonomic nervous system had a variable effect on aldosterone but often appeared to reduce the rate of steroid secretion in the sodiumdepleted group.
Also, I call your attention to the effect of infusion of these pressor agents on sodium excretion by the kidnley. Iln this particular group, before sodium depletion, all of them caused a reduced sodium excretion. But after sodium depletion, all tended to cause an increased urinary sodium content, regardless of their influence on aldosterone secretion. The effect of intraventous infusion of pressor substances. i-S cm pared be 'fore andl (after sodium depletion in normal subjects on a metabolismi icarl coiistan)dt (lietary regimnen. The pressor agents were given in 5 per cent dextr-ose solution? w{ith aC constant infusion pump for periods of fromt 5 to 24 hours. The average icrement ini blood pressure produced by the infusion is shown. The open boxes represent cont-rol calues for each experiment, during which glucose infusion wtas given wvithoat a pressor aget. It canl be seen that angiotensin always produced ain increase in the secretory rate of aldosterone. By contrast, medullary hormones had a variable effect but tended to suppress the elevated aldosterone secretion of sodiuem depletion. Infusion of call of these agents lended to produce sodium retention before sodium depletion. Howecer, after sodiumi (lepletion, all tendled to be ntatrinretic. regairdless of th.ei-r effe(ct on. aldosteronie.
Trhe iinatriuretie actioii of these pressor agents in sodiuimc-depleted subjects seemeed worthy of further investigation. We have now studied over 20 subjects and have also examlimied the effects of various other sympathonmimetic agents. At the preselit timiie, it is fair to say that frequently, but certainly inot always, significanit natriuresis can be ilnduced in sodium-depleted subjects by the adininistration of pressor drugs, either orally or intravenously. This point is aniplified in figure 2 . where the effect of the infusioin of various pressor substances giveni before anid againi after sodium depletion to 2 normal subjects anid to 1 subject with uncoirplicated. hvpertension is illustrated. The lnatriuretic actioni of these pressor agents onlv oceurred after sodiuin depletion; the effect. well demonstrated in the normal subject, was not so nmarked in this particular patienit with hypertensioni. l'thus fmir, it hlas I-)eetl imiipossible to dletermiinle wlieln of' the various pressor agenits is miiost niatriuretic because the results have Ilot revealed a oH0sistent patterni amuong differeint subjects. Trhe slight inatriuresis of this hypertensive suibject is perhaps of less nmagniitude thani has been reported. I would like to suggest, however, that possibly the miatriuiresis reported by several groups'5 ') in hypertensive subjects after aiigioteusin is i.ot altogether unique for this group of patients; also, it mav niot be entirely specific for angaiotensin. FFurther studies which conitr ol sodiumil balalmee andl wvhich compare varlious pressor agents may be necessary,.
In a number of previous studies of pressor substances, different effects o0) electrolyte andl wvater exeretioln have been observed. Somne of these differenices m-lay be explainied by differences in experimenital conditions, particularly in the durationi of the studies. Thus, iin whereas before clepletion, variable effects on sodium exeretiont were observed. Angiotensin also increased sodium excretion after sodium depletion but only very slightly. Responses similar to normal subjects were encountered in a patient writh benign essential hypertension. acute clearance studies, SIythe. Nickel, and Bradley16 demonstrated a dimiinlished sodium and potassium excretion and a tendency to loss of water during the pressor action of adrenal medullary hormones. Subsequently, this group showed17 that these effects could occur with dosages which did not change the pulse or arterial pressure. Angiotensin and ephedrine produced different effects on electrolyte excretion. It was suggested that the effects of pressor agents on sodium and potassium excretion might be an indireet result of alterations in renal hemodynamics. Other clearance Circulation, Volume XXV, January 1962 studies'8' 9 have indicated that reniin differs from norepinephrine because renin, at times, produced a diuresis and natriuresis while inducing changes in renal blood flow and glomerular filtration which appeared similar to norepinephrine.
The studies reported in this communication are of a more prolonged nature, with the infusions of pressor substances having been carried out for from 5 to 24 hours. Therefore, the different effects on electrolyte and water excretion from those noted during acute clearance studies may be a reflection of addi- The patient shown above (MI.L.) exhibited a pressor responzse to relatively low dosages given over an 8-hour period in isotonic glucose by constant infusion pump. In contrast, the patient shotw n below (P.S.) required very large dosages of both agetts to elevate the blood pressure. Marked nzatriureesis was produced in the second patient wvhein larxger doses of angiotensin were given. In both patients, in marked contrctst to w7hat is found inz nor1mal subjects, angiotensin failed to autgment aldlosteronze secretion. The reduced pressor sensitivity a,nd the failufre to augment (lldosteronze with angiotensin perhaps may be taken as eridence for an endogenous excess of renin anzd an giotenisii in this disorder. tional or secondary hemodynamic and hormonial adjustments associated with a longer experiment. As you will hear, Tuttle has infused these substancees for still longer periods and has obtainied still different response patternis.
Is Angiotensin the Trophic Hormone for
Aldosterone ?-Studies in Cirrhosis Because angiotensin consistently stimulates ldopsterQne $ecretion, the question is raised as to whether this peptide is the principal trophic hormone for aldosterone. This action of angiotensin fits well with the findilng of oversecretion of aldosterone in malignant hypertelnsion. However, in malignant hypertension, there is severe renal damage, which miaht cause inappropriate release of renin. You will recall that neither renin nor angiotensin has been incontrovertibly demonstrated in normal plasma, and it thus remains possible that the effect of angiotensin on aldosterone is pharmacologic rather than physiologic. On the other hand, these findings may mean that a renal-adrenal mechanism exists which operates for normal control of sodium balance. There is already conisiderable indirect evidence for the existence of such a system, implicating renin release by the juxtaglomerular cells and aldosterone secretion by the adrenal cortex.20 ' 21 Finally, I would like to consider briefly the effects of pressor acents in patients with cirrhosis anid ascites ( fig. 3 ). These patients characteristically excrete virtually no sodiutm (often less than 1 mEq./day), and, in our hands, their rate of aldosterone secretion is uspually hiaher than in any other disorder. Aldosterone seems especially important in the pathogenesis of this edema since complete diuresis may follow adrenalectomy and since the aldosterone antagonists (spirolactones) are especiallv effective in these patients. Patienits with cirrhosis and ascites may therefore re-present a -particularly useful model for studv of the faetors concerned in the normal reylilation of aldosterone secretion.
We have reasoned that if anoiotensin is the trophic hormone for aldosterone, one might exTect patients with eirrhosis and ascites to manifest arterial hypertension unless some sort of tolerance or tachynhylaxis to angiotensin has developed. In figure 3 , it can be seen that. in fact, patients with eirrhosis may be relatively resistant to the pressor elTects of synthetic angiotensin. At times (patient P.S.), much larger doses are required to produce a blood pressure elevation; however, to date, whenever this situation has been encountered, much more norepinephrine has also been required. There is, therefore, no evidence as yet that the reduced pressor responsiveness of these patients is unique for angiotensin.
One might deduce from these findings that patients with cirrhosis are secreting excessive, but subpressor, amounts of renin to account for the increased aldosterone output. The failure of exogenous angiotensin to augment aldosterone secretion might thus mean that these patients are already maximally stimulated.
Alternatively, one may interpret the findings in cirrhosis to mean that angiotensin is really not the trophic hormone for regulating aldosterone secretion. The reduced pressor sensitivity could be nonspecific, and the failure of angiotensin to stimulate further aldosterone secretion might mean that the adrenal cortex is preferenltially receptive to a stimulus other than angiotensin, perhaps the trophic hormone, which is present in great excess in these patients. Because of the nature or the degree of stuch a stimulus, the adrenal cortex is preclusively engaged.
Despite these reservations, it is the author's view that the renin-angiotensin system could well be the main trophic hormonal system for reglulation of aldosterone secretion. Tlyperactivity of such a system would explain the oversecretion of aldosterone in malignant hypertension and might account for other instances of physiologic andi pathologic aldosterollism. But a critical experiment remains to be donie, i.e., the demonstration of renin or of angiotensin in increased amounts in the eirculation of sodium-depleted normal subjects or of patients with edema who have increased aldosterone secretion.
In closing, consider the striking natriuresis which can also be produced in patients with cirrhosis and ascites by various pressor agents. includingm botlh norepiniephrine and angiotensin. In 8 studies, -we have founid that the anaiotensin produces a much more marked natriuresis in these patients than does norepinephrine. This finding raises the question once more as to whether there is anything unique about the lnatriuretic effects of angiotensin reported in patients with arterial hyperten-Circulation, Volume XXV, Jasnuary 1962 sion.13'15 Further studies of this phenomenon which utilize more precise technics of renal clearance are necessary.
Summary
Oversecretion of aldosterone is a consistent findinig in the syndrome of malignant hypertension. Infusion of angiotensin has been consistently shown to induce an increased secretion of aldosterone by the adrenal cortex in normal human subjects. Because renal damage is so prominent in malignant hypertension, it seems possible that renin release and then aldosterone oversecretion by the adrenal cortex are involved in the pathogenesis of this disorder.
These findings support the possibility that there is a renal-adrenal system which operates for the normal regulation of electrolyte balance. This system might function to maintain and protect renal perfusion by promoting sodium retention via stimulation of the adrenal cortex.
Our recent work has been predicated on the possibility that aldosterone secretion is chiefly regulated by 1 specific trophic hormone (possibly angiotensin), oversecretion of which accounts for the increased secretion of aldosterone observed in various other conditions. Preliminary studies designed to in'vestigate the possible role of angiotensin in the marked oversecretion of aldosterone found in cirrhosis have been reported. It has been observed that patienits with cirrhosis and ascites may be less sensitive to both angiotensin and norepineplhrine so that more drug is required to produce a given pressor response. Furthermore, aldosterone secretion could not be augmented by administering angiotensin in these patients. WhIile several interpretations are possible, these findings are consistent with the view that the adrenal cortex is already maximally stimulated by circulating endogenous angiotensin.
Because of reduced pressor responsiveness, increased amounts of angiotensin could circulate without causing hypertension. This hypothesis awaits actual demonstration of increased amounts of eirculatinog renin or LARAGII angiotensin in this condition (ancd others) associated with aldosteronism.
Proper study of the interrelationships between pressor substances, aldosteronie see retion, and sodiumn balance requires that effects of the differenit types of pressor agents be compared under similar eircumstances. Thus. both norepinepbriiie and angiotensin affect the renal exeretioin of electrolytes. Both cani (cause a natriuresis in normal or hypertensive subLjects. In normal sub,jects. the natriuresis oceurs ineonsistently but seenis more readily iniduced after sodiuim depletioni.
Angiotenisin has been found to prodluce a t miiarked increase in sodium exeretionl in patients with cirrhosis anid aseites who have inereased aldosterolne secretion. TIn equipressor doses, the niatriuresis of angiotensini is of strikingly greater magnitude than that of norepinephrine, possibly indicating that the peptide affeets tubular transport of sodiumil. The natriuresis effected by these pressor agents seems inidepencde-nt of their eflect oni aldosterone seeretion because itiedull1arv hormones often suppress aldosterone ouitput. whereas angiotensiii inereases it.
Further study is necessarv to define more specifically the conditions whieh determine these responses and interr-lationships. The results to date support the view that an aldosterone-regulating hormone (possibly anigiotensin) could be elaborated as a result of a critical change in intrarenal pressure.
